Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 55 entries
Sorted by: Best Match Show Resources per page
Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

Mazzulli T, Skulnick M, Small G, Marshall W, Hoban DJ, Zhanel GG, Finn S, Low DE.
PMID: 18159352
Can J Infect Dis. 2001 Sep;12(5):289-92. doi: 10.1155/2001/601743.

OBJECTIVE: To determine the susceptibility of community outpatient Gram-negative urinary tract isolates to mecillinam and other commonly used oral agents.DESIGN AND SETTING: The study was a laboratory-based study of consecutive Gram-negative urinary tract isolates. Only those isolates considered to...

Cite
Mazzulli T, Skulnick M, Small G, et al. Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents. Can J Infect Dis. 2001;12(5):289-92doi: 10.1155/2001/601743.
Mazzulli, T., Skulnick, M., Small, G., Marshall, W., Hoban, D. J., Zhanel, G. G., Finn, S., & Low, D. E. (2001). Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 12(5), 289-92. https://doi.org/10.1155/2001/601743
Mazzulli, T, et al. "Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents." The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 12,5 (2001): 289-92. doi: https://doi.org/10.1155/2001/601743
Mazzulli T, Skulnick M, Small G, Marshall W, Hoban DJ, Zhanel GG, Finn S, Low DE. Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents. Can J Infect Dis. 2001 Sep;12(5):289-92. doi: 10.1155/2001/601743. PMID: 18159352; PMCID: PMC2094837.
Copy Download .nbib Format: NLM
Oligella infections: Case report and review of the literature.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

Baqi M, Mazzulli T.
PMID: 22514466
Can J Infect Dis. 1996 Nov;7(6):377-9. doi: 10.1155/1996/153512.

A case of Oligella ureolytica infection of a cervical lymph node is presented and previous cases of oligella infection reported in the literature are reviewed. Underlying malignancy and urinary tract obstruction were observed in many of the cases. All...

Cite
Baqi M, Mazzulli T. Oligella infections: Case report and review of the literature. Can J Infect Dis. 1996;7(6):377-9doi: 10.1155/1996/153512.
Baqi, M., & Mazzulli, T. (1996). Oligella infections: Case report and review of the literature. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 7(6), 377-9. https://doi.org/10.1155/1996/153512
Baqi, M, and Mazzulli, T. "Oligella infections: Case report and review of the literature." The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 7,6 (1996): 377-9. doi: https://doi.org/10.1155/1996/153512
Baqi M, Mazzulli T. Oligella infections: Case report and review of the literature. Can J Infect Dis. 1996 Nov;7(6):377-9. doi: 10.1155/1996/153512. PMID: 22514466; PMCID: PMC3327428.
Copy Download .nbib Format: NLM
Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

Weinstein MR, Low DE, Mazzulli T.
PMID: 22514489
Can J Infect Dis. 1997 May;8(3):164-6. doi: 10.1155/1997/706456.

In vitro studies have shown that Mycobacterium marinum is usually susceptible to clarithromycin. However, there are limited published data on the clinical use of clarithromycin for the treatment of M marinum infections. This report describes a previously healthy 58-year-old...

Cite
Weinstein MR, Low DE, Mazzulli T. Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection. Can J Infect Dis. 1997;8(3):164-6doi: 10.1155/1997/706456.
Weinstein, M. R., Low, D. E., & Mazzulli, T. (1997). Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 8(3), 164-6. https://doi.org/10.1155/1997/706456
Weinstein, M R, et al. "Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection." The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 8,3 (1997): 164-6. doi: https://doi.org/10.1155/1997/706456
Weinstein MR, Low DE, Mazzulli T. Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection. Can J Infect Dis. 1997 May;8(3):164-6. doi: 10.1155/1997/706456. PMID: 22514489; PMCID: PMC3327350.
Copy Download .nbib Format: NLM
Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment.

Frontiers in endocrinology

Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R, Mazzilli R, Ferrero S, Palagiano A, Rienzi L.
PMID: 30842755
Front Endocrinol (Lausanne). 2019 Feb 20;10:94. doi: 10.3389/fendo.2019.00094. eCollection 2019.

Advanced maternal age (AMA; >35 year) is associated with a decline in both ovarian reserve and oocyte competence. At present, no remedies are available to counteract the aging-related fertility decay, however different therapeutic approaches can be offered to women...

Cite
Ubaldi FM, Cimadomo D, Vaiarelli A, et al. Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Front Endocrinol (Lausanne). 2019;10:94doi: 10.3389/fendo.2019.00094.
Ubaldi, F. M., Cimadomo, D., Vaiarelli, A., Fabozzi, G., Venturella, R., Maggiulli, R., Mazzilli, R., Ferrero, S., Palagiano, A., & Rienzi, L. (2019). Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Frontiers in endocrinology, 1094. https://doi.org/10.3389/fendo.2019.00094
Ubaldi, Filippo Maria, et al. "Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment." Frontiers in endocrinology vol. 10 (2019): 94. doi: https://doi.org/10.3389/fendo.2019.00094
Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R, Mazzilli R, Ferrero S, Palagiano A, Rienzi L. Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment. Front Endocrinol (Lausanne). 2019 Feb 20;10:94. doi: 10.3389/fendo.2019.00094. eCollection 2019. PMID: 30842755; PMCID: PMC6391863.
Copy Download .nbib Format: NLM
Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking.

Neuron

Stojkovska I, Wani WY, Zunke F, Belur NR, Pavlenko EA, Mwenda N, Sharma K, Francelle L, Mazzulli JR.
PMID: 34793693
Neuron. 2021 Nov 09; doi: 10.1016/j.neuron.2021.10.032. Epub 2021 Nov 09.

Neurodegenerative disorders are characterized by a collapse in proteostasis, as shown by the accumulation of insoluble protein aggregates in the brain. Proteostasis involves a balance of protein synthesis, folding, trafficking, and degradation, but how aggregates perturb these pathways is...

Cite
Stojkovska I, Wani WY, Zunke F, et al. Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking. Neuron. 2021;doi: 10.1016/j.neuron.2021.10.032.
Stojkovska, I., Wani, W. Y., Zunke, F., Belur, N. R., Pavlenko, E. A., Mwenda, N., Sharma, K., Francelle, L., & Mazzulli, J. R. (2021). Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking. Neuron, . https://doi.org/10.1016/j.neuron.2021.10.032
Stojkovska, Iva, et al. "Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking." Neuron vol. (2021). doi: https://doi.org/10.1016/j.neuron.2021.10.032
Stojkovska I, Wani WY, Zunke F, Belur NR, Pavlenko EA, Mwenda N, Sharma K, Francelle L, Mazzulli JR. Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking. Neuron. 2021 Nov 09; doi: 10.1016/j.neuron.2021.10.032. Epub 2021 Nov 09. PMID: 34793693.
Copy Download .nbib Format: NLM
Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo.

Proceedings of the National Academy of Sciences of the United States of America

Fredriksen K, Aivazidis S, Sharma K, Burbidge KJ, Pitcairn C, Zunke F, Gelyana E, Mazzulli JR.
PMID: 34893541
Proc Natl Acad Sci U S A. 2021 Dec 14;118(50). doi: 10.1073/pnas.2108489118.

No abstract available.

Cite
Fredriksen K, Aivazidis S, Sharma K, et al. Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo. Proc Natl Acad Sci U S A. 2021;118(50)doi: 10.1073/pnas.2108489118.
Fredriksen, K., Aivazidis, S., Sharma, K., Burbidge, K. J., Pitcairn, C., Zunke, F., Gelyana, E., & Mazzulli, J. R. (2021). Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo. Proceedings of the National Academy of Sciences of the United States of America, 118(50), . https://doi.org/10.1073/pnas.2108489118
Fredriksen, Kristina, et al. "Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo." Proceedings of the National Academy of Sciences of the United States of America vol. 118,50 (2021). doi: https://doi.org/10.1073/pnas.2108489118
Fredriksen K, Aivazidis S, Sharma K, Burbidge KJ, Pitcairn C, Zunke F, Gelyana E, Mazzulli JR. Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivo. Proc Natl Acad Sci U S A. 2021 Dec 14;118(50). doi: 10.1073/pnas.2108489118. PMID: 34893541.
Copy Download .nbib Format: NLM
Hepatitis C virus testing in a clinical HIV cohort in Ontario, Canada, 2000 to 2015.

Health science reports

Moqueet N, Grewal R, Mazzulli T, Cooper C, Gardner SL, Salit IE, Kroch A, Burchell AN.
PMID: 34568583
Health Sci Rep. 2021 Sep 18;4(3):e358. doi: 10.1002/hsr2.358. eCollection 2021 Sep.

BACKGROUND: HIV-positive individuals may acquire HCV via injection drug use (IDU) and condomless anal sex. HIV care provides opportunities for HCV testing and cure with direct-acting antiviral agents (DAAs).METHODS: We analyzed data from the Ontario HIV Treatment Network Cohort...

Cite
Moqueet N, Grewal R, Mazzulli T, et al. Hepatitis C virus testing in a clinical HIV cohort in Ontario, Canada, 2000 to 2015. Health Sci Rep. 2021;4(3):e358doi: 10.1002/hsr2.358.
Moqueet, N., Grewal, R., Mazzulli, T., Cooper, C., Gardner, S. L., Salit, I. E., Kroch, A., Burchell, A. N. (2021). Hepatitis C virus testing in a clinical HIV cohort in Ontario, Canada, 2000 to 2015. Health science reports, 4(3), e358. https://doi.org/10.1002/hsr2.358
Moqueet, Nasheed, et al. "Hepatitis C virus testing in a clinical HIV cohort in Ontario, Canada, 2000 to 2015." Health science reports vol. 4,3 (2021): e358. doi: https://doi.org/10.1002/hsr2.358
Moqueet N, Grewal R, Mazzulli T, Cooper C, Gardner SL, Salit IE, Kroch A, Burchell AN. Hepatitis C virus testing in a clinical HIV cohort in Ontario, Canada, 2000 to 2015. Health Sci Rep. 2021 Sep 18;4(3):e358. doi: 10.1002/hsr2.358. eCollection 2021 Sep. PMID: 34568583; PMCID: PMC8449285.
Copy Download .nbib Format: NLM
Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review.

Pharmaceuticals (Basel, Switzerland)

La Salvia A, Sesti F, Grinzato C, Mazzilli R, Tarsitano MG, Giannetta E, Faggiano A.
PMID: 34681263
Pharmaceuticals (Basel). 2021 Oct 12;14(10). doi: 10.3390/ph14101039.

Neuroendocrine neoplasms (NENs) are relatively rare and complex tumors that can be sporadic or hereditary, as in the context of multiple endocrine neoplasia type 1 (MEN1) where patients display a 70% lifelong risk of developing a pancreatic NENs (pNENs)....

Cite
La Salvia A, Sesti F, Grinzato C, et al. Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review. Pharmaceuticals (Basel). 2021;14(10)doi: 10.3390/ph14101039.
La Salvia, A., Sesti, F., Grinzato, C., Mazzilli, R., Tarsitano, M. G., Giannetta, E., & Faggiano, A. (2021). Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review. Pharmaceuticals (Basel, Switzerland), 14(10), . https://doi.org/10.3390/ph14101039
La Salvia, Anna, et al. "Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review." Pharmaceuticals (Basel, Switzerland) vol. 14,10 (2021). doi: https://doi.org/10.3390/ph14101039
La Salvia A, Sesti F, Grinzato C, Mazzilli R, Tarsitano MG, Giannetta E, Faggiano A. Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review. Pharmaceuticals (Basel). 2021 Oct 12;14(10). doi: 10.3390/ph14101039. PMID: 34681263; PMCID: PMC8538402.
Copy Download .nbib Format: NLM
Federated Learning used for predicting outcomes in SARS-COV-2 patients.

Research square

Flores M, Dayan I, Roth H, Zhong A, Harouni A, Gentili A, Abidin A, Liu A, Costa A, Wood B, Tsai CS, Wang CH, Hsu CN, Lee CK, Ruan C, Xu D, Wu D, Huang E, Kitamura F, Lacey G, Corradi GCA, Shin HH, Obinata H, Ren H, Crane J, Tetreault J, Guan J, Garrett J, Park JG, Dreyer K, Juluru K, Kersten K, Rockenbach MABC, Linguraru M, Haider M, AbdelMaseeh M, Rieke N, Damasceno P, Silva PMCE, Wang P, Xu S, Kawano S, Sriswa S, Park SY, Grist T, Buch V, Jantarabenjakul W, Wang W, Tak WY, Li X, Lin X, Kwon F, Gilbert F, Kaggie J, Li Q, Quraini A, Feng A, Priest A, Turkbey B, Glicksberg B, Bizzo B, Kim BS, Tor-Diez C, Lee CC, Hsu CJ, Lin C, Lai CL, Hess C, Compas C, Bhatia D, Oermann E, Leibovitz E, Sasaki H, Mori H, Yang I, Sohn JH, Murthy KNK, Fu LC, de Mendonça MRF, Fralick M, Kang MK, Adil M, Gangai N, Vateekul P, Elnajjar P, Hickman S, Majumdar S, McLeod S, Reed S, Graf S, Harmon S, Kodama T, Puthanakit T, Mazzulli T, Lavor VL, Rakvongthai Y, Lee YR, Wen Y.
PMID: 33442676
Res Sq. 2021 Jan 08; doi: 10.21203/rs.3.rs-126892/v1.

'Federated Learning' (FL) is a method to train Artificial Intelligence (AI) models with data from multiple sources while maintaining anonymity of the data thus removing many barriers to data sharing. During the SARS-COV-2 pandemic, 20 institutes collaborated on a...

Cite
Flores M, Dayan I, Roth H, et al. Federated Learning used for predicting outcomes in SARS-COV-2 patients. Res Sq. 2021;doi: 10.21203/rs.3.rs-126892/v1.
Flores, M., Dayan, I., Roth, H., Zhong, A., Harouni, A., Gentili, A., Abidin, A., Liu, A., Costa, A., Wood, B., Tsai, C. S., Wang, C. H., Hsu, C. N., Lee, C. K., Ruan, C., Xu, D., Wu, D., Huang, E., Kitamura, F., Lacey, G., Corradi, G. C. A., Shin, H. H., Obinata, H., Ren, H., Crane, J., Tetreault, J., Guan, J., Garrett, J., Park, J. G., Dreyer, K., Juluru, K., Kersten, K., Rockenbach, M. A. B. C., Linguraru, M., Haider, M., AbdelMaseeh, M., Rieke, N., Damasceno, P., Silva, P. M. C. E., Wang, P., Xu, S., Kawano, S., Sriswa, S., Park, S. Y., Grist, T., Buch, V., Jantarabenjakul, W., Wang, W., Tak, W. Y., Li, X., Lin, X., Kwon, F., Gilbert, F., Kaggie, J., Li, Q., Quraini, A., Feng, A., Priest, A., Turkbey, B., Glicksberg, B., Bizzo, B., Kim, B. S., Tor-Diez, C., Lee, C. C., Hsu, C. J., Lin, C., Lai, C. L., Hess, C., Compas, C., Bhatia, D., Oermann, E., Leibovitz, E., Sasaki, H., Mori, H., Yang, I., Sohn, J. H., Murthy, K. N. K., Fu, L. C., de Mendonça, M. R. F., Fralick, M., Kang, M. K., Adil, M., Gangai, N., Vateekul, P., Elnajjar, P., Hickman, S., Majumdar, S., McLeod, S., Reed, S., Graf, S., Harmon, S., Kodama, T., Puthanakit, T., Mazzulli, T., Lavor, V. L., Rakvongthai, Y., Lee, Y. R., & Wen, Y. (2021). Federated Learning used for predicting outcomes in SARS-COV-2 patients. Research square, . https://doi.org/10.21203/rs.3.rs-126892/v1
Flores, Mona, et al. "Federated Learning used for predicting outcomes in SARS-COV-2 patients." Research square vol. (2021). doi: https://doi.org/10.21203/rs.3.rs-126892/v1
Flores M, Dayan I, Roth H, Zhong A, Harouni A, Gentili A, Abidin A, Liu A, Costa A, Wood B, Tsai CS, Wang CH, Hsu CN, Lee CK, Ruan C, Xu D, Wu D, Huang E, Kitamura F, Lacey G, Corradi GCA, Shin HH, Obinata H, Ren H, Crane J, Tetreault J, Guan J, Garrett J, Park JG, Dreyer K, Juluru K, Kersten K, Rockenbach MABC, Linguraru M, Haider M, AbdelMaseeh M, Rieke N, Damasceno P, Silva PMCE, Wang P, Xu S, Kawano S, Sriswa S, Park SY, Grist T, Buch V, Jantarabenjakul W, Wang W, Tak WY, Li X, Lin X, Kwon F, Gilbert F, Kaggie J, Li Q, Quraini A, Feng A, Priest A, Turkbey B, Glicksberg B, Bizzo B, Kim BS, Tor-Diez C, Lee CC, Hsu CJ, Lin C, Lai CL, Hess C, Compas C, Bhatia D, Oermann E, Leibovitz E, Sasaki H, Mori H, Yang I, Sohn JH, Murthy KNK, Fu LC, de Mendonça MRF, Fralick M, Kang MK, Adil M, Gangai N, Vateekul P, Elnajjar P, Hickman S, Majumdar S, McLeod S, Reed S, Graf S, Harmon S, Kodama T, Puthanakit T, Mazzulli T, Lavor VL, Rakvongthai Y, Lee YR, Wen Y. Federated Learning used for predicting outcomes in SARS-COV-2 patients. Res Sq. 2021 Jan 08; doi: 10.21203/rs.3.rs-126892/v1. PMID: 33442676; PMCID: PMC7805458.
Copy Download .nbib Format: NLM
Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results.

Infection control and hospital epidemiology

Gubbay JB, Rilkoff H, Kristjanson HL, Forbes JD, Murti M, Eshaghi A, Broukhanski G, Corbeil A, Fittipaldi N, Hopkins JP, Kristjanson E, Kus JV, Macdonald L, Majury A, Mallo GV, Mazzulli T, Melano RG, Olsha R, Perusini SJ, Tran V, Allen VG, Patel SN.
PMID: 34369325
Infect Control Hosp Epidemiol. 2021 Aug 09;1-18. doi: 10.1017/ice.2021.369. Epub 2021 Aug 09.

OBJECTIVES: Performance characteristics of SARS-CoV-2 nucleic acid detection assays are understudied within contexts of low pre-test probability, including screening asymptomatic persons without epidemiological links to confirmed cases, or asymptomatic surveillance testing. SARS-CoV-2 detection without symptoms may represent presymptomatic or...

Cite
Gubbay JB, Rilkoff H, Kristjanson HL, et al. Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results. Infect Control Hosp Epidemiol. 2021;1-18doi: 10.1017/ice.2021.369.
Gubbay, J. B., Rilkoff, H., Kristjanson, H. L., Forbes, J. D., Murti, M., Eshaghi, A., Broukhanski, G., Corbeil, A., Fittipaldi, N., Hopkins, J. P., Kristjanson, E., Kus, J. V., Macdonald, L., Majury, A., Mallo, G. V., Mazzulli, T., Melano, R. G., Olsha, R., Perusini, S. J., Tran, V., Allen, V. G., & Patel, S. N. (2021). Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results. Infection control and hospital epidemiology, 1-18. https://doi.org/10.1017/ice.2021.369
Gubbay, Jonathan B, et al. "Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results." Infection control and hospital epidemiology vol. (2021): 1-18. doi: https://doi.org/10.1017/ice.2021.369
Gubbay JB, Rilkoff H, Kristjanson HL, Forbes JD, Murti M, Eshaghi A, Broukhanski G, Corbeil A, Fittipaldi N, Hopkins JP, Kristjanson E, Kus JV, Macdonald L, Majury A, Mallo GV, Mazzulli T, Melano RG, Olsha R, Perusini SJ, Tran V, Allen VG, Patel SN. Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results. Infect Control Hosp Epidemiol. 2021 Aug 09;1-18. doi: 10.1017/ice.2021.369. Epub 2021 Aug 09. PMID: 34369325.
Copy Download .nbib Format: NLM
Identifying host microRNAs in bronchoalveolar lavage samples from lung transplant recipients infected with Aspergillus.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Gohir W, Klement W, Singer LG, Palmer SM, Mazzulli T, Keshavjee S, Husain S.
PMID: 32771440
J Heart Lung Transplant. 2020 Nov;39(11):1228-1237. doi: 10.1016/j.healun.2020.07.014. Epub 2020 Jul 25.

BACKGROUND: MicroRNAs (miRNAs) are small non-coding RNAs of ∼22 nucleotides that play a crucial role in post-transcriptional regulation of gene expression. Dysregulation of miRNA expression has been shown during microbial infections. We sought to identify miRNAs that distinguish invasive...

Cite
Gohir W, Klement W, Singer LG, et al. Identifying host microRNAs in bronchoalveolar lavage samples from lung transplant recipients infected with Aspergillus. J Heart Lung Transplant. 2020;39(11):1228-1237doi: 10.1016/j.healun.2020.07.014.
Gohir, W., Klement, W., Singer, L. G., Palmer, S. M., Mazzulli, T., Keshavjee, S., & Husain, S. (2020). Identifying host microRNAs in bronchoalveolar lavage samples from lung transplant recipients infected with Aspergillus. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 39(11), 1228-1237. https://doi.org/10.1016/j.healun.2020.07.014
Gohir, Wajiha, et al. "Identifying host microRNAs in bronchoalveolar lavage samples from lung transplant recipients infected with Aspergillus." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation vol. 39,11 (2020): 1228-1237. doi: https://doi.org/10.1016/j.healun.2020.07.014
Gohir W, Klement W, Singer LG, Palmer SM, Mazzulli T, Keshavjee S, Husain S. Identifying host microRNAs in bronchoalveolar lavage samples from lung transplant recipients infected with Aspergillus. J Heart Lung Transplant. 2020 Nov;39(11):1228-1237. doi: 10.1016/j.healun.2020.07.014. Epub 2020 Jul 25. PMID: 32771440.
Copy Download .nbib Format: NLM
Whipple's Disease in an Afro-Caribbean National.

The West Indian medical journal

Whittle DO, Williams NP, Nicholson AM, King-Robinson K, Kirsch R, Riddell R, Mazzulli T, Lee MG.
PMID: 25303201
West Indian Med J. 2014 Jan;63(1):101-4. doi: 10.7727/wimj.2012.220. Epub 2014 Jan 06.

Whipple's disease is a rare multi-organ infectious disease caused by Tropheryma whipplei. It is fatal without treatment. We report on a 40-year old Afro-Jamaican man who presented with a six-month history of weight loss and diarrhoea. Investigations revealed iron...

Cite
Whittle DO, Williams NP, Nicholson AM, et al. Whipple's Disease in an Afro-Caribbean National. West Indian Med J. 2014;63(1):101-4doi: 10.7727/wimj.2012.220.
Whittle, D. O., Williams, N. P., Nicholson, A. M., King-Robinson, K., Kirsch, R., Riddell, R., Mazzulli, T., & Lee, M. G. (2014). Whipple's Disease in an Afro-Caribbean National. The West Indian medical journal, 63(1), 101-4. https://doi.org/10.7727/wimj.2012.220
Whittle, D O, et al. "Whipple's Disease in an Afro-Caribbean National." The West Indian medical journal vol. 63,1 (2014): 101-4. doi: https://doi.org/10.7727/wimj.2012.220
Whittle DO, Williams NP, Nicholson AM, King-Robinson K, Kirsch R, Riddell R, Mazzulli T, Lee MG. Whipple's Disease in an Afro-Caribbean National. West Indian Med J. 2014 Jan;63(1):101-4. doi: 10.7727/wimj.2012.220. Epub 2014 Jan 06. PMID: 25303201; PMCID: PMC4655628.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 55 entries